The Atomoxetine Hydrochloride Capsules Market is propelled by several powerful growth drivers. Rising global ADHD prevalence, now affecting approximately 7.2% of children and adolescents worldwide, creates sustained demand for effective treatments. Increasing awareness and diagnosis rates, particularly in previously underdiagnosed adult populations, significantly expand the patient base. The...